{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:44:50Z","timestamp":1788176690083,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","heartrhythmjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.hrthm.2017.09.011","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T06:31:13Z","timestamp":1505370673000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation"],"prefix":"10.1016","volume":"15","author":[{"given":"Rhanderson","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Knijnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bhonsale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0785-6704","authenticated-orcid":false,"given":"Guilherme","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Blumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2017.09.011_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.09.011_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.09.011_bib4","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.09.011_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/europace\/euv132","article-title":"Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA)","volume":"17","author":"Potpara","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.09.011_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10840-016-0221-7","volume":"48","author":"Zhao","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib7","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"Di Biase","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.09.011_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijcard.2015.03.376","article-title":"Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation","volume":"187","author":"Nairooz","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.cjca.2015.09.012","article-title":"Uninterrupted new oral anticoagulants compared with uninterrupted vitamin K antagonists in ablation of atrial fibrillation: a meta-analysis","volume":"32","author":"Nairooz","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"376","author":"Calkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2017.09.011_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jce.12928","article-title":"Apixaban versus Warfarin for the prevention of periprocedural cerebral thromboembolism in atrial fibrillation ablation: multicenter prospective randomized study","volume":"27","author":"Kuwahara","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10840-016-0214-6","article-title":"Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin","volume":"48","author":"Tao","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jjcc.2016.03.014","article-title":"Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation","volume":"69","author":"Yoshimura","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib14","author":"Wells"},{"key":"10.1016\/j.hrthm.2017.09.011_bib15","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2017.09.011_bib16","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2017.09.011_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","article-title":"Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study","volume":"12","author":"Di Biase","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.09.011_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCEP.114.001586","article-title":"Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures","volume":"7","author":"Dillier","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10840-012-9719-9","article-title":"Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin","volume":"35","author":"Konduru","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2013.11.039","article-title":"Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"63","author":"Lakkireddy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/jce.12143","article-title":"Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation","volume":"24","author":"Maddox","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib22","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.hrthm.2015.04.016","article-title":"Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation","volume":"12","author":"Nagao","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.09.011_bib23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amjcard.2017.04.041","article-title":"Safety and efficacy of uninterrupted apixaban therapy versus warfarin during atrial fibrillation ablation","volume":"120","author":"Shah","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib24","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.09.011_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10840-014-9924-9","article-title":"Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation","volume":"41","author":"Naccarelli","year":"2014","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/europace\/euv190","volume":"17","author":"Sticherling","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.09.011_bib27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2011.12.014","article-title":"Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"59","author":"Lakkireddy","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1540-8167.2011.02050.x","article-title":"Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon","volume":"22","author":"Gaita","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"Vermeer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2017.09.011_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.hrthm.2011.01.020","article-title":"Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin","volume":"8","author":"Latchamsetty","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.09.011_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jce.12918","article-title":"Management of periprocedural and early pericardial effusions with tamponade following ablation of atrial fibrillation with uninterrupted factor Xa inhibitors: a case series","volume":"27","author":"Gianni","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.09.011_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527117310901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527117310901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T14:00:48Z","timestamp":1535378448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527117310901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1547527117310901"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2017.09.011","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2017.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}